References
- Jones R H, Lydeard S E, Hobbs F DR, et al. Dyspepsia in England and Scotland. Gut 1990; 31: 401–405
- Kagevi I, Löfstedt S, Persson L G. Endoscopic findings and diagnosis in unselected dyspeptic patients at a primary health care center. Scand J Gastroenterol 1989; 24: 145–150
- Kristensen P, Sandbakken P, Johannessen T, et al. Fordøyelsessykdommer i almenpraksis. En praksisregistrering. Tidsskr Nor Laegeforen 1985; 105: 728–731
- Colin-Jones D G, et al. Management of dyspepsia: report from a working party. Lancet 1988; 1: 576–579
- Nyrén O, Adami H O, Bates S, et al. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med 1986; 314: 339–343
- Talley N J, McNeil D, Hayden A, Piper D W. Randomized, double-blind, placebo-controlled crossover trial of cimetidine and pirenzepine in non-ulcer dyspepsia. Gastroenterology 1986; 91: 149–156
- Lance P, Wastell C, Schiller K FR. A controlled trial of cimetidine for the treatment of non-ulcer dyspepsia. J Clin Gastroenterol 1986; 8: 414–418
- Saunders J BH, Oliver R J, Higson D L. Dyspepsia: incidence on non-ulcer disease in controlled trial of ranitidine in general practice. Br Med J 1986; 292: 665–668
- Nesland A A, Berstad A. Effect of cimetidine in patients with non-ulcer dyspepsia and erosive pre-pyloric changes. Scand J Gastroenterol 1985; 20: 629–635
- Gotthard R, Bodemar G, Brodin U, Jönsson K Å. Treatment with cimetidine, antacid, or placebo in patients with dyspepsia of unknown origin. Scand J Gastroenterol 1988; 23: 7–18
- Kelbæk H, Linde J, Eriksen J, Munkgaard S, Moesgaard F, Bonnevie O. Controlled clinical trial of treatment with cimetidine for non-ulcer dyspepsia. Acta Med Scand 1985; 217: 281–287
- Kleveland P M, Larsen S, Sandvik L, et al. The effect of cimetidine in non-ulcer dyspepsia. Experience with a multi-cross-over model. Scand J Gastroenterol 1985; 20: 19–24
- Johannessen T, Fjøsne U, Kleveland P M, et al. Cimetidine responders in non-ulcer dyspepsia. Scand J Gastroenterol 1988; 23: 327–336
- Nesland A A, Berstad A. Erosive prepyloric changes in persons with and without dyspepsia. Scand J Gastroenterol 1985; 20: 222–228
- Aabakken L, Larsen S, Osnes M. Visual analogue scales for endoscopic evaluation of nonsteroidal anti-inflammatory drug-induced mucosal damage in the stomach and duodenum. Scand J Gastroenterol 1990; 25: 443–448
- Larsen S, Farup P, Flaten O, Osnes M. The multi-crossover model for classifying patients as responders to a given treatment. Scand J Gastroenterol 1991; 26: 763–771
- Kendall M, Stuart A, Ord J K. The advanced theory of statistics. Charles Griffin & Co. Ltd, London 1983; Vol III
- Cox D R, Oakes D. Analysis of survival data. Chapman and Hall, London 1984
- Hand D J. Discrimination and classification. John Wiley & Sons, New York 1981
- Kendall M, Stuart A. The advanced theory of statistics. Charles Griffin & Co. Ltd, London 1979; Vol. II
- Deruyttere M, Milo R, Creytens G, Goethals C, Bourgeois E, Offner E. Therapy of chronic functional dyspepsia: multicentre cross-over study of cisapride and placebo. Prog Med 1987; 43 Suppl 1: 61–68
- Rösch W. Cisapride in non-ulcer dyspepsia. Results of a placebo-controlled trial. Scand J Gastroenterol 1987; 22: 161–164
- Kerrigan D D, Mangnall Y F, Read N W, Johnson A G. Cimetidine delays gastric emptying of solid food. Gastroenterology 1989; 96: A253
- Karnad D R, Abraham P, Rathod N M, Nasarath H M. Test for H2-receptor antagonist response in non-ulcer dyspepsia. Lancet 1990; 1: 657–658
- Tytgat G NJ, Nicolai J J, Reman F C. Efficacy of different doses of cimetidine in the treatment of reflux oesophagitis: a review of three large, double-blind, controlled trials. Gastroenterology 1990; 99: 629–634